A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis

NCT06406205 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Nephritis

Interventions

DRUG: Voclosporin（QL1074）
DRUG: Placebo

Sponsor

Qilu Pharmaceutical Co., Ltd.